Cargando…
Development of a computed tomography-based radiomics nomogram for prediction of transarterial chemoembolization refractoriness in hepatocellular carcinoma
BACKGROUND: Some patients with hepatocellular carcinoma (HCC) are more likely to experience disease progression despite continuous transarterial chemoembolization (TACE), which is called TACE refractoriness. At present, it is still difficult to predict TACE refractoriness, although some models/scori...
Autores principales: | Niu, Xiang-Ke, He, Xiao-Feng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7807298/ https://www.ncbi.nlm.nih.gov/pubmed/33510559 http://dx.doi.org/10.3748/wjg.v27.i2.189 |
Ejemplares similares
-
Simultaneous transarterial chemoembolization and radiofrequency ablation for large hepatocellular carcinoma
por: Duan, Feng, et al.
Publicado: (2020) -
Evaluation of the relationship between hepatocellular carcinoma location and transarterial chemoembolization efficacy
por: Miki, Izumi, et al.
Publicado: (2017) -
Analysis of aggressiveness factors in hepatocellular carcinoma patients undergoing transarterial chemoembolization
por: Ventura, Yossi, et al.
Publicado: (2018) -
Idarubicin vs doxorubicin in transarterial chemoembolization of intermediate stage hepatocellular carcinoma
por: Roth, Gaël Stéphane, et al.
Publicado: (2020) -
Transarterial chemoembolization using 40 µm drug eluting beads for hepatocellular carcinoma
por: Greco, Giorgio, et al.
Publicado: (2017)